| Revenue growth | Standalone +18% YoY; consolidated +16% |
|---|---|
| Margins | Standalone EBITDA margin 10.8% vs 12.6%; input costs elevated |
| Demand visibility | TiO2 ADD reimposed on China; double-digit demand growth |
Growth
Standalone revenue +18% YoY, PAT +6%. Consolidated revenue +16%, PAT ₹33.9 Cr vs ₹11.6 Cr.
Outlook
No explicit growth guidance given. Capacity additions include 5,000 MTPA MPP plant; nano DAP, NPK and zinc launches planned.
Risks
Elevated input and logistics costs compressing margins. Pigment utilisation 51%, crop protection utilisation 72%.
Last quarter's promises, checked
Delivered
- Pigment ₹550-600 Cr annualised → ₹161.5 Cr/qtr (×4≈₹646 Cr) (= BEAT)
- Crop Protection double-digit growth → +12% YoY (= BEAT)
- Pigment utilisation 40-50% → 51% (= BEAT)
Partly delivered
- Nano DAP/NPK/Zinc 'newly introduced' → still 'planned' (= PARTIAL)
Missed
- Overall margin 12-13% → standalone EBITDA 10.8% (= MISS)
- ~₹130 Cr yearly repayment → ST debt ₹474→₹495 Cr (= MISS)
Investor Presentation filed with NSE, NSE: MOL. Summary written with AI assistance from the document.
Meghmani Organics Ltd: key numbers
- Share price
- ₹55.95
- Market cap
- ₹1,423 Cr
- Revenue (annual)
- ₹2,174 Cr
- Net profit (annual)
- ₹28.74 Cr
- P/E (TTM)
- 22.1×Sector 33.9×
- Promoter holding
- 48.95%+0.00% QoQ
- FII holding
- 0.84%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Meghmani Organics Ltd
All →Meghmani Organics Results Update
MOL reported Q2 FY27 revenue of ₹658.2 crore, up 18% YoY, with net profit of ₹45.3 crore. EBITDA margin eased to 10.8% on elevated input costs.
Meghmani Organics Q2 FY27 Results: Net Profit ₹33.9 Cr, Up 192.2% YoY
Meghmani Organics Ltd reported revenue from operations of ₹666.9 Cr (+15.5% YoY) and net profit of ₹33.9 Cr (+192.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹33.9 Cr · +192.2% YoY
Meghmani Organics Credit Rating
India Ratings assigned Meghmani Organics' bank loan facilities of INR 11,000 million a rating of IND A/Stable/IND A1. The filing encloses the rating letter and a facilities breakup.
Meghmani Organics Board Meeting Date
Meghmani Organics will hold a board meeting on 4 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The meeting is a future notice, so no results are yet reported.
Meghmani Organics Other Announcement
Meghmani Organics Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended September 30, 2026.
Meghmani Organics Acquisition
Meghmani Organics Limited received an NCLT Ahmedabad Bench order sanctioning the Scheme of Amalgamation of its wholly-owned subsidiaries, Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited, with itself.